Benjamin Li
Apr 15, 2013

Pfizer consolidates all consumer healthcare brands with Leo Burnett Shanghai

SHANGHAI - After a competitive pitch process in Q1, Pfizer has appointed Leo Burnett Shanghai to handle the strategic and creative communication development for Centrum, Pro-nutrient and Imedeen in the China market.

Pfizer consolidates with LB Shanghai
Pfizer consolidates with LB Shanghai

Leo Burnett reported that the participants in the pitch included the incumbent agency TBWA, DDB and Leo Burnett. A TBWA spokesperson confirmed that TBWA was the incumbent, having started with Centrum four years ago. 

Leo Burnett Shanghai has also handled Caltrate and Robitussin for more than seven years.

"Our aim is to look for an agency partner that best understands our market and business needs, with proven abilities to deliver insightful and effective integrated communications for our brands," said Keith Choy, regional general manager, Pfizer Consumer Healthcare, China and Hong Kong. "After careful consideration, we decided that a consolidation of all our PCH brands into Leo Burnett best suits our requirements." 

Donald Chan, group chief executive officer of Leo Burnett China, commented that consumer healthcare is one of the fastest growing and highly competitive categories.

Source:
Campaign Asia

Related Articles

Just Published

14 hours ago

Alibaba pledges 'aggressive' AI investment, reports ...

Revenue jumped 8% as Alibaba's AI-driven strategy paid off. A surge in investor confidence has sent its share price soaring over 60% since the start of the year.

15 hours ago

Five by Five Global to deliver AI-powered campaigns ...

Can creativity truly be compressed? Former Cheil Australia MD Mark Anderson, now at Five by Five Global, is betting big on AI with a new seven-hour sprint model to find out.

19 hours ago

BBDO launches new global vision to focus on bolder ...

'Do Big Things' will empower brands to take risks, make noise, and tackle the world's biggest problems with bold solutions, says global CEO Nancy Reyes.

20 hours ago

Is Elon Musk’s X winning back advertisers?

Social media platform X is reportedly in talks to raise money at its buying price valuation of $44 billion, despite user and advertiser losses since Elon Musk’s acquisition in 2022.